Curative Biosciences (Curative Biosciences) ROCE % : 0.00% (As of Mar. 2018)

View and export this data going back to 2004. Start your Free Trial

What is Curative Biosciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Curative Biosciences's annualized ROCE % for the quarter that ended in Mar. 2018 was 0.00%.

Curative Biosciences ROCE % Historical Data

The historical data trend for Curative Biosciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biosciences ROCE % Chart

Curative Biosciences Annual Data

Trend

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

ROCE %

Get a 7-Day Free Trial

Curative Biosciences Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

Curative Biosciences ROCE % Calculation

Curative Biosciences's annualized ROCE % for the fiscal year that ended in Jun. 2017 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2017 )		(A: Jun. 2016 )		(A: Jun. 2017 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2017 )		(A: Jun. 2016 )		(A: Jun. 2017 )
	=	-0.053	/	( ( (0.005 - 0.62)	+	(0.002 - 0.633) )	/ 2 )
	=	-0.053	/	( (-0.615	+	-0.631)	/ 2 )
	=	-0.053	/	-0.623
	=	8.51 %

Curative Biosciences's ROCE % of for the quarter that ended in Mar. 2018 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2018 )		(Q: Dec. 2017 )		(Q: Mar. 2018 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2018 )		(Q: Dec. 2017 )		(Q: Mar. 2018 )
	=	-0.128	/	( ( (0.001 - 0.675)	+	(0.014 - 0.72) )	/ 2 )
	=	-0.128	/	( ( -0.674	+	-0.706 )	/ 2 )
	=	-0.128	/	-0.69
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2018) EBIT data.

Curative Biosciences (OTCPK:CBDX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Curative Biosciences ROCE % Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Curative Biosciences (Curative Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curative Biosciences Inc (OTCPK:CBDX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131

Website

http://www.CurativeBio.com

Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.

Curative Biosciences (Curative Biosciences) Headlines

No Headlines